For Healthcare

SOX plus regulated-evidence overlap for healthcare mid-market

Agent-driven control testing that understands the PCAOB evidence bar, HIPAA safeguard expectations, and HITRUST or SOC 2 overlap — so healthcare finance teams do not run parallel evidence stacks for each framework.

Who we built this for

The persona

Controller or Internal Audit Director at a 300 to 1,500 employee healthcare mid-market company — provider group, medical device, digital health platform, or healthcare services.

The specific pain: Healthcare mid-market teams run SOX or SOX-readiness on top of HIPAA, HITECH, and frequently additional compliance frameworks (HITRUST, SOC 2) — meaning the controller faces a stack of overlapping evidence obligations, and a generalist SOX platform does not handle the regulated-vertical evidence overlap.

Executive summary

The Healthcare positioning in one read.

Healthcare mid-market companies — physician group practices, ambulatory surgery centers, medical device manufacturers, digital health platforms, healthcare services firms, specialty pharmacy operations — face a uniquely layered compliance burden. The SOX program (for public or PE-portco healthcare operations) or SOX-readiness program (for pre-IPO digital health or medical device companies) sits on top of HIPAA (Health Insurance Portability and Accountability Act, 45 CFR §§ 160-164), HITECH (Health Information Technology for Economic and Clinical Health Act, 42 U.S.C. §§ 17921-17954), and frequently HITRUST CSF certification or SOC 2 Type II attestation obligations from health-plan or health-system customers.

The overlap is substantial. HIPAA Security Rule administrative, physical, and technical safeguards (45 CFR §§ 164.308-164.312) share significant evidence with SOX ITGC — access review, change management, audit logging, incident response, backup and disaster recovery. HITRUST CSF v11's foundational controls map to SOC 2 TSC and SOX ITGC in well-defined patterns. Healthcare Controllers running the stack often maintain parallel evidence collection — one copy for SOX walkthrough, one copy for HIPAA safeguard demonstration, one copy for HITRUST certification. Prova's evidence schema intentionally aligns on the overlap points so a single test execution produces evidence usable across all three frameworks; the framework-mapping layer tags evidence with the applicable framework reference for the specific compliance attestation.

Control catalog

Concrete controls Prova covers at Healthcare scope

This is not a feature list — it is a control-by-control mapping showing which specific SOX / ICFR controls Prova’s agent tests continuously at Healthcare scope, and what the coverage actually produces. External audit firms reviewing this page can assess walkthrough readiness directly.

Control IDCategoryProva coverage
HC-HIPAA-ACCESS-01HIPAA § 164.308(a)(4) access authorization + SOX ITGC access review overlapEHR access review with HIPAA minimum-necessary standard applied alongside SOX role-entitlement analysis. Epic + Cerner + Allscripts + athenahealth supported via administrative API and audit-log export.
HC-HIPAA-AUDIT-01HIPAA § 164.312(b) audit controls + SOX evidence logging overlapEHR audit log ingestion, access-attempt monitoring, PHI-access anomaly detection. Single log stream satisfies HIPAA Technical Safeguard audit controls and SOX change-management evidence.
HC-HIPAA-CHANGE-01HIPAA § 164.308(a)(1) security management + SOX change management overlapChange management process for EHR + clinical-system deployments. Security risk assessment integration (HIPAA § 164.308(a)(1)(ii)(A)) tied to change-management approval workflow.
HC-HITRUST-CONTROL-01HITRUST CSF v11 foundational controls mappingFoundational HITRUST CSF controls tagged with SOC 2 TSC and SOX ITGC mapping. Single evidence-production workflow satisfies multiple attestations per test execution.
HC-SOC2-01SOC 2 Type II Trust Services Criteria overlapSOC 2 TSC CC6.1-CC6.3 (logical access), CC6.6-CC6.7 (network + data protection), CC7.1-CC7.4 (monitoring + incident response), CC8.1 (change management). 85-90% overlap with SOX ITGC.
HC-REVENUE-01Healthcare revenue recognition (ASC 606 + ASC 326) controlsHealthcare-specific ASC 606 implementation (patient-service-revenue recognition, variable-consideration for payor mix, implicit price concessions) + ASC 326 allowance for credit losses (payor-specific collectability analysis).
HC-340B-01340B compliance controls (if applicable)340B Drug Pricing Program eligibility verification, patient-definition controls, covered-outpatient-drug tracking. For safety-net healthcare providers with 340B enrollment.
HC-FCA-01False Claims Act compliance controlsBilling-integrity controls, medical-necessity documentation review, fraud-risk-assessment integration. Aligned to OIG Compliance Program Guidance for healthcare providers.
HC-HIPAA-BREACH-01HIPAA breach notification + incident responsePagerDuty + Jira incident ticket ingestion with HIPAA breach-notification-timing tracking (60-day individual notification, annual HHS notification for breaches under 500 individuals). Integrates with § 164.408 individual notification workflow.
HC-STATE-PRIVACY-01State-level healthcare privacy controlsCalifornia CCPA + CMIA (Confidentiality of Medical Information Act), Texas medical privacy, New York SHIELD Act, Washington My Health My Data Act. Framework-mapping layer tags evidence per applicable state law.
HC-BAA-01Business Associate Agreement (BAA) complianceVendor access control testing with BAA status verification. Third-party risk management integration for covered-entity + business-associate relationships under HIPAA § 164.308(b).
HC-FDA-01FDA 21 CFR Part 11 electronic records controls (medical device)Medical-device electronic-records control testing under FDA 21 CFR Part 11 (electronic records and signatures). Overlap with SOX ITGC change management and audit logging.

Annual audit timeline

The Healthcare SOX calendar

  1. Phase 01

    Q1

    Annual multi-framework scoping

    Activities

    SOX scope review plus HIPAA Security Risk Analysis (annual requirement under 45 CFR § 164.308(a)(1)(ii)(A)) plus HITRUST CSF scope (if certified) plus SOC 2 scope (if attested). Framework-mapping layer updated for new controls.

    Artifacts produced

    Updated multi-framework control library, HIPAA Security Risk Analysis, HITRUST scope document, SOC 2 scope letter.

  2. Phase 02

    Q1-Q2

    Q1-Q2 continuous testing + HIPAA-overlay evidence

    Activities

    Continuous agent-produced evidence across multi-framework scope. HIPAA audit-log review, PHI-access monitoring, breach-notification readiness testing. SOX interim testing cycle.

    Artifacts produced

    Q1 + Q2 attestation packages, HIPAA quarterly safeguard evidence, SOC 2 continuous monitoring evidence.

  3. Phase 03

    Varies (typically Q2-Q3)

    HITRUST certification or SOC 2 attestation engagement

    Activities

    HITRUST external assessor engagement (if certifying) or SOC 2 Type II attestation engagement (if attesting). Overlap evidence ingestion by assessor / auditor. Deficiency remediation if required.

    Artifacts produced

    HITRUST CSF certification report or SOC 2 Type II attestation letter, deficiency remediation log, assessor / auditor walkthrough memo.

  4. Phase 04

    Q4

    Q4 year-end SOX testing + consolidated framework review

    Activities

    Year-end SOX testing completion, external audit firm walkthrough, HIPAA annual Security Risk Analysis refresh, HITRUST + SOC 2 annual scope review.

    Artifacts produced

    Year-end SOX attestation package, HIPAA Security Risk Analysis annual refresh, framework-consolidation memo for audit committee.

  5. Phase 05

    Q4/Q1 boundary

    Annual audit committee + compliance committee review

    Activities

    Audit committee year-end ICFR review (public filers) or sponsor year-end review (PE portcos). Compliance committee HIPAA + HITRUST + SOC 2 review. Multi-framework deficiency disclosure and remediation planning.

    Artifacts produced

    Audit committee year-end report, compliance committee multi-framework report, forward-year remediation plan.

Use cases

Where Healthcare teams actually deploy Prova

Use case 01

Digital health platform pre-IPO readiness (SOX + HIPAA + SOC 2)

Digital health platforms 12-18 months pre-IPO face a triple-compliance readiness challenge: SOX for the S-1 filing, HIPAA for the covered-entity or business-associate operations, and SOC 2 Type II for health-plan and health-system customer contracts. Each framework has its own external assessor or auditor relationship, its own evidence format, and its own deadline. Prova's multi-framework evidence-schema-alignment handles this natively — a single test execution for EHR access review produces HIPAA § 164.308(a)(4) evidence, SOC 2 TSC CC6.1 evidence, and SOX ITGC access-review evidence simultaneously. The framework-mapping layer tags evidence per framework for the specific assessor / auditor package.

Use case 02

Physician group practice PE portco with HIPAA overlay

PE-owned physician group practices (healthcare services PE is a large and growing sub-sector) face HIPAA compliance obligations at every operating practice plus SOX obligations at the portco level (common for multi-practice platforms). Each practice's EHR (Epic, Cerner, athenahealth, PracticeFusion, Kareo) produces HIPAA Security Rule evidence; the portco-level rollup produces SOX ICFR evidence. Prova's per-entity scoping plus multi-framework alignment supports this architecture: each practice entity produces HIPAA evidence, the portco parent consolidates SOX evidence, and the framework-mapping layer keeps each framework's evidence stream clean for its respective assessor.

Use case 03

Medical device manufacturer with FDA 21 CFR Part 11 overlap

Medical device manufacturers face FDA 21 CFR Part 11 electronic-records requirements on top of SOX ICFR. Part 11 governs electronic records and electronic signatures for FDA-regulated processes (manufacturing records, quality-system records, clinical-trial records); the evidence overlap with SOX ITGC change management and audit logging is significant. Prova's medical-device-industry integrations include quality-management-system (MasterControl, Veeva QualityOne) audit-log ingestion that produces simultaneous Part 11 electronic-records evidence and SOX ITGC change-management evidence. Multi-framework medical-device customers report 50-70% reduction in evidence-collection overhead compared to parallel framework-specific evidence workstreams.

Use case 04

340B Drug Pricing Program compliance (safety-net providers)

340B-enrolled healthcare providers (safety-net hospitals, FQHCs, critical access hospitals) face 340B compliance on top of SOX obligations (for publicly-traded health systems) or governance obligations (for non-profit health systems). 340B compliance covers eligibility verification, patient-definition controls, covered-outpatient-drug tracking, and HRSA audit readiness. Prova's 340B-specific control library integrates with pharmacy-operations systems (Sentry Data Systems, SpendMend, 340B Health) for continuous 340B-compliance evidence production. For health-system customers with both SOX obligations and 340B compliance scope, the integrated platform produces both framework's evidence from a single deployment.

Use case 05

State-level healthcare privacy compliance (CMIA, SHIELD, My Health My Data)

Healthcare mid-market companies typically operate in 3-8 state jurisdictions, each with its own healthcare-privacy-law overlay. California's CMIA (Confidentiality of Medical Information Act), Texas's medical-privacy framework, New York's SHIELD Act, Washington's My Health My Data Act, and emerging state-level health-privacy laws add evidence-tagging requirements on top of HIPAA and HITRUST. Prova's state-level framework-mapping tags evidence per applicable state law so the Controller can produce state-specific evidence packages without running parallel state-level evidence workstreams. Healthcare customers report the state-level overlay handling as one of the highest-value multi-framework features.

Use case 06

Business Associate Agreement (BAA) compliance for HIPAA covered-entity + BA structures

Healthcare mid-market companies acting as HIPAA business associates (to covered-entity health plans and health systems) or as covered entities themselves (to business-associate vendors) face BAA compliance obligations under HIPAA § 164.308(b). BAA compliance requires vendor access control testing, vendor-specific evidence of appropriate PHI handling, and breach-notification coordination. Prova's third-party risk management integration tracks BAA status per vendor and integrates vendor access control testing with BAA-status verification. For customers with 20-40 active BAAs (common for larger healthcare mid-market companies), the automated BAA-compliance workflow is a meaningful operational simplification.

Regulatory deep-dive

PCAOB, SEC, and Sarbanes-Oxley references that apply at Healthcare scope.

Healthcare mid-market compliance operates under a compound regulatory framework spanning SOX, HIPAA, HITECH, HITRUST CSF, SOC 2, state-level healthcare privacy laws, False Claims Act, and sector-specific frameworks (FDA 21 CFR Part 11 for medical device, 340B Drug Pricing Program for safety-net providers, Stark Law and Anti-Kickback Statute for provider compensation). The SOX framework applies per the standard Sarbanes-Oxley §§ 302/404/906 and PCAOB AS 2201 regime for public filers and PE portcos; the healthcare-specific overlays layer additional evidence obligations.

HIPAA (45 CFR Parts 160-164) and HITECH (42 U.S.C. §§ 17921-17954) govern PHI protection with three rules: the Privacy Rule (45 CFR § 164.500-534), the Security Rule (45 CFR § 164.302-318), and the Breach Notification Rule (45 CFR § 164.400-414). The Security Rule's administrative (§§ 164.308), physical (§§ 164.310), and technical (§§ 164.312) safeguards overlap substantially with SOX ITGC, which is why multi-framework evidence alignment is operationally valuable. HITRUST CSF v11 provides a certifiable framework mapping HIPAA, NIST 800-53, ISO 27001, PCI DSS, and SOC 2 criteria; HITRUST certification signals to health-plan and health-system customers that the organization meets the healthcare-industry-specific security bar.

False Claims Act (31 U.S.C. §§ 3729-3733) compliance adds anti-fraud control obligations for healthcare providers, payers, and vendors, with per-claim civil penalties ranging from $13,946 to $27,894 (2024 adjusted) plus three-times damages and additional qui tam whistleblower mechanics. Stark Law (42 U.S.C. § 1395nn) and the Anti-Kickback Statute (42 U.S.C. § 1320a-7b) govern physician self-referral and kickback relationships with criminal penalties for willful violations. FDA 21 CFR Part 11 governs electronic records and signatures for FDA-regulated processes (medical device manufacturing, quality-system records, clinical-trial records). Each of these adds its own evidence-production and evidence-retention requirements on top of SOX; multi-framework evidence-schema alignment is the highest-leverage operational optimization available to healthcare Controllers managing the compound compliance burden.

Pricing context

What Prova typically costs at Healthcare scope.

Healthcare mid-market Prova ACV typically lands $35,000 to $65,000 per year for a 400-1,200 employee healthcare company with SOX plus HIPAA scope, scaling to $55,000 to $90,000 per year for companies with HITRUST certification or SOC 2 Type II attestation in addition. The premium over non-healthcare mid-market pricing reflects the broader control-library scope (typically 60-90 controls for healthcare vs 40-60 for non-healthcare at similar employee band) and the framework-mapping layer operational overhead. Against the alternative of running parallel framework-specific platforms (AuditBoard for SOX + Vanta or Drata for SOC 2 + a HITRUST-specific tool + HIPAA-specific point solutions), healthcare mid-market customers typically see 60-75% cost reduction by consolidating on Prova's multi-framework evidence schema.

What this page covers

Six questions Healthcare buyers ask

  1. 01

    How do SOX controls overlap with HIPAA safeguards in a healthcare mid-market company?

  2. 02

    Can Prova reuse evidence across SOX, HIPAA, HITRUST, and SOC 2?

  3. 03

    What does access-review testing look like for EHR-adjacent systems (Epic, Cerner, Allscripts)?

  4. 04

    How does agent-driven change management work for regulated healthcare deployments?

  5. 05

    How does the external audit firm handle healthcare-specific evidence?

  6. 06

    What does cost look like for a mid-market healthcare company with multiple regulated frameworks?

Full answers, concrete dollar figures, and PCAOB-aligned evidence walkthroughs for each question are shipping across the blog and product pages through Cohort 1. Readers who want the long-form treatment before the content lands: request a design partner slot and we will send the draft memo.

FAQ for Healthcare

Questions Controllers at this stage ask

Does Prova support HIPAA or HITRUST evidence?
SOX is the primary scope and the PCAOB evidence bar is the primary optimization target. For healthcare customers, Prova's evidence schema intentionally aligns on the overlap points — access review, audit logging, change management, incident handling — so a single test execution produces evidence usable for the SOX walkthrough and the HIPAA Security Rule safeguard demonstration. Full HITRUST-certification workflow is on the roadmap, not a Cohort 1 promise.
How does Prova handle EHR access-review testing?
EHR systems (Epic, Cerner, Allscripts, athenahealth) integrate via their administrative APIs and audit-log exports. The access-review agent reasons about entitlement appropriateness in the same pattern as an Okta or Workday source — with the additional dimension that HIPAA minimum-necessary standards affect what counts as appropriate access. This dimensional layering is live in Cohort 1 with two healthcare design partners.
What about regional compliance frameworks (state-level privacy, CMS)?
State-level privacy (California CCPA and CMIA, Texas medical privacy, New York SHIELD Act) and CMS compliance overlays add to the evidence surface; the framework-mapping layer allows a single control test execution to emit evidence tagged for each applicable framework. Healthcare mid-market customers typically operate in 3 to 8 state jurisdictions and appreciate not running a dedicated evidence stack per state.
Is healthcare Phase 1 or Phase 2?
Healthcare mid-market is part of Cohort 1 with dedicated design partners — specifically the SOX + HIPAA + SOC 2 overlap case. The full HITRUST certification workflow is Phase 2. Healthcare customers today should expect strong SOX coverage with meaningful HIPAA evidence reuse, and a clear roadmap for HITRUST depth.
How does Prova handle 340B Drug Pricing Program compliance?
For 340B-enrolled healthcare providers (safety-net hospitals, FQHCs, critical access hospitals), Prova's 340B control library integrates with pharmacy-operations platforms (Sentry Data Systems, SpendMend, 340B Health) for continuous 340B compliance evidence. Eligibility verification, patient-definition controls, covered-outpatient-drug tracking, and HRSA audit readiness are all in scope. For health-system customers with both SOX obligations and 340B compliance, the integrated platform produces both framework's evidence from a single deployment.
What about FDA 21 CFR Part 11 for medical device manufacturers?
Medical device manufacturers running FDA-regulated electronic records systems (quality management, manufacturing, clinical trials) face 21 CFR Part 11 evidence requirements on top of SOX ITGC. Prova's integrations with MasterControl, Veeva QualityOne, and other QMS platforms produce simultaneous Part 11 electronic-records evidence and SOX ITGC change-management evidence from a single control-test execution. Part 11 compliance specifics (electronic signature validity, audit trail immutability, validation documentation) integrate with the SOX evidence stream through the framework-mapping layer.

Global FAQ

Questions that apply across every stage

Is Prova priced by company size, control count, or per entity?
Prova is priced per entity because the scope of testing is per entity. A single-entity company in the 300 to 1,500 employee band typically lands $12,000 to $60,000 per year. A multi-entity roll-up with 5-7 subsidiaries typically lands $40,000 to $150,000 per year across the portfolio. Control-count does not drive pricing beyond the entity boundary.
How does Prova's evidence satisfy PCAOB AS 2201 §.39 four-characteristic requirements?
Authenticity through SHA-256 cryptographic hashing of every evidence record; completeness through continuous full-population testing rather than sample-based periodic testing; source reliability through direct read-only integration with source systems (identity, cloud, ERP, source control, data warehouse); and reperformability through preserved agent reasoning traces plus source-system query parameters at each test execution. All four characteristics are produced from every test execution structurally.
What about data residency and PHI / PII exposure?
Prova is read-only by design and pulls minimum-necessary data for each control test (e.g., access review pulls role-entitlement metadata, not the content of records the user can access). Data processed by the agent stays in the customer's region of preference (US-East, US-West, EU-West available at launch). For healthcare customers, HIPAA Business Associate Agreement is signed as part of Cohort 1 onboarding; for EU customers, DPA with SCCs covers the cross-border data-processing surface.
How does Prova handle external audit firm workpaper integration?
Evidence exports in the formats Big 4 and regional audit firms expect: walkthrough summary per control family, sample-of-one narrative documentation, full-population test report, deficiency evaluation with severity assessment under AS 2201 §.50. Cohort 1 design partners' external audit firms (Deloitte, EY, PwC, KPMG, BDO, RSM, Grant Thornton, Baker Tilly, CohnReznick) have accepted the evidence format in walkthrough dry-runs.

Design partner program · Cohort 1

Request a design partner slot.

Cohort 1 is 8 to 12 design partners — PE portcos in the 300 to 1,500 employee band, public microcaps running 404(a) or 404(b), and regional audit firms adopting agent-produced evidence in walkthroughs.

Design partners get concierge onboarding, a dry-run walkthrough with your external audit partner before year-end, and founder-level access to the roadmap. In exchange we ask for 60 minutes every two weeks.

We will only email you about Prova. No newsletter list, no tracking pixels, no shared contact data.